Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
about
Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis.High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cellsGlucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesAdamantyl glycosphingolipids provide a new approach to the selective regulation of cellular glycosphingolipid metabolism.Acute ethanol causes hepatic mitochondrial depolarization in mice: role of ethanol metabolism.Efflux-mediated antifungal drug resistance.Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.Glycosphingolipid functionsVerotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy.Vps11, a subunit of the tethering complexes HOPS and CORVET, is involved in regulation of glycolipid degradation and retrograde toxin transport.Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?Biochemical, pathological and oncological relevance of Gb3Cer receptor
P2860
Q33412880-BCE4EF8E-5BA6-4DAB-8AC8-077056CE4CF6Q33503956-2D6936F3-C08A-4F2C-941E-CD1858D64989Q33630801-39AB3624-CC83-4262-AB35-77B32E939DE2Q33991690-F436BD99-46D1-4D4C-9F97-A5B2745F944AQ34148357-E22C121C-3A26-4BC1-A058-3AB478C6AE3BQ34329204-5B5C12AA-E358-4FE9-8615-A856CA47FDEAQ35065197-9EA7F794-9EDB-4BA7-8CDF-3CE53F5ED7B7Q35117523-292AC8C1-4805-412A-8092-CE1564C971D6Q37156645-B27D027D-117A-457C-9DD8-350ACCA8E484Q37591813-79685126-5D96-471A-868E-3378C0AF22D3Q37873655-12C461EE-C482-49B0-B387-5747BEB8F1D5Q37954271-B6EFFCA1-9B58-4371-8BEA-7A4E138EA103Q38897970-5082A796-9470-40A8-A2C8-AF513A93655FQ39421907-D6E29D21-3068-4719-AE31-185AA2EB59F4Q57117659-ECE53966-06A4-46DA-887E-0A37210B8BF1
P2860
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
@en
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
@nl
type
label
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
@en
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
@nl
prefLabel
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
@en
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
@nl
P2093
P2860
P356
P1476
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
@en
P2093
Bernice Wang
Cameron Ackerley
Clifford Lingwood
David M Clarke
María Fabiana De Rosa
Shinya Ito
P2860
P304
P356
10.1074/JBC.M705473200
P407
P577
2007-11-13T00:00:00Z